BSX logo

Boston Scientific Corporation (BSX)

$43.03

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BSX

Market cap

$62.37B

EPS

2.36

P/E ratio

17.3

Price to sales

2.95

Dividend yield

--

Beta

0.601956

Price on BSX

Previous close

$43.69

Today's open

$43.28

Day's range

$43.02 - $43.83

52 week range

$39.57 - $102.71

Profile about BSX

CEO

Michael F. Mahoney

Employees

59000

Headquarters

Marlborough, MA

Exchange

New York Stock Exchange

Shares outstanding

1.45B

Issue type

Common Stock

BSX industries and sectors

Healthcare

Medical Equipment & Supplies

News on BSX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

news source

GlobeNewsWire • Nov 17, 2026

news preview

Should You Book Profits or Hold BSX Stock Post-Q3 Earnings?

Boston Scientific BSX saw modest sales growth in the third quarter, with revenues climbing 1.5% year over year to $5.14 billion, though its adjusted earnings per share (“EPS”) dipped 2.7% to 73 cents year over year. Primarily due to unexpected headwinds within two high-growth franchises, WATCHMAN and Electrophysiology (“EP”), the company lowered its expectations for the rest of the year.

news source

Zacks Investment Research • Nov 16, 2026

news preview

Bear of the Day: Boston Scientific (BSX)

I last wrote about Boston Scientific ( BSX ) as the Bear of the Day in early August after their Q2 report and management's lowered guidance propelled analysts to notch down their EPS estimates for this year and next, causing BSX shares to fall into the cellar of the Zacks Rank.

news source

Zacks Investment Research • Nov 13, 2026

news preview

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

NEW YORK, Nov. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

news source

PRNewsWire • Nov 12, 2026

news preview

Boston Scientific Bets on WATCHMAN Growth Despite Market Slowdown

BSX bets on WATCHMAN growth through clinical trials and physician outreach, even as slowing demand and rising competition cloud its outlook.

news source

Zacks Investment Research • Nov 12, 2026

news preview

Boston Scientific Targets Long-Term Growth as Key Businesses Face Pressure Through 2027

Boston Scientific NYSE: BSX executives said they expect durable growth across the company's interventional portfolio, while acknowledging that its pulsed field ablation and WATCHMAN businesses face competitive challenges through 2027.

news source

MarketBeat • Nov 11, 2026

news preview

Boston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 Transcript

Boston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Nov 11, 2026

news preview

Wall Street Analysts Look Bullish on Boston Scientific (BSX): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

news source

Zacks Investment Research • Nov 10, 2026

news preview

BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation's Directors and Officers for Breach of Fiduciary Duties – BSX

NEW YORK--(BUSINESS WIRE)---- $BSX #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Boston Scientific in an acceptable manner, breaching their fiduciary duties to Boston Scientific, and whether Boston Scientific and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On February 4, 2026, B.

news source

Business Wire • Nov 5, 2026

news preview

Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is a Trending Stock

Boston Scientific (BSX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

news source

Zacks Investment Research • Nov 5, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Boston Scientific Corporation

Open an M1 investment account to buy and sell Boston Scientific Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BSX on M1